|4Dec 18, 5:00 PM ET

Dubovsky Filip 4

4 · NOVAVAX INC · Filed Dec 18, 2023

Insider Transaction Report

Form 4
Period: 2023-12-14
Dubovsky Filip
President, R&D
Transactions
  • Exercise/ConversionSwap

    Restricted Stock Units

    2023-12-142,8330 total
    Common Stock (2,833 underlying)
  • Exercise/ConversionSwap

    Common Stock

    2023-12-14$5.69/sh+2,833$16,12055,150 total
  • Tax PaymentSwap

    Common Stock

    2023-12-14$5.69/sh1,368$7,78453,782 total
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
  • [F2]The RSUs subject to this grant under the Plan vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment with the Company through such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION